Kissei Pharmaceutical Co Ltd (4547.T) Analysts | Reuters.com
Edition:
United States

Kissei Pharmaceutical Co Ltd (4547.T)

4547.T on Tokyo Stock Exchange

2,046JPY
2:00am EDT
Change (% chg)

¥-20 (-0.97%)
Prev Close
¥2,066
Open
¥2,098
Day's High
¥2,098
Day's Low
¥2,039
Volume
149,600
Avg. Vol
128,338
52-wk High
¥3,460
52-wk Low
¥1,915

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 30 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 4.00 4.00 4.00 4.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-16 1 72,000.00 72,000.00 72,000.00 --
Year Ending Mar-17 1 71,100.00 71,100.00 71,100.00 72,150.00
Year Ending Mar-18 1 71,200.00 71,200.00 71,200.00 77,800.00
Earnings (per share)
Year Ending Mar-16 2 158.39 159.42 157.37 --
Year Ending Mar-17 2 151.24 163.51 138.98 152.26
Year Ending Mar-18 2 134.89 167.59 102.19 180.48

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-15 16,300.00 16,676.00 376.00 2.31
Quarter Ending Mar-15 16,380.00 17,490.00 1,110.00 6.78
Quarter Ending Dec-14 14,990.00 18,010.00 3,020.00 20.15
Quarter Ending Sep-14 16,159.00 18,769.00 2,610.00 16.15
Quarter Ending Mar-14 16,071.00 17,046.00 975.00 6.07

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-16 72,000.00 -- -- -- --
Year Ending Mar-17 71,100.00 71,100.00 72,000.00 72,000.00 72,150.00
Year Ending Mar-18 71,200.00 71,200.00 74,400.00 74,400.00 77,800.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-16 -- -- -- --
Year Ending Mar-17 0 0 0 1
Year Ending Mar-18 0 0 0 1
Earnings

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$300.00
Provider : Wright Reports
$75.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.